Skip to content

Dynamic Cardio-vascular, Cerebro-vascular and Cortical Interaction in Healthy Adult Subjects

Dynamic Cardio-, Cerebro-vascular and Cortical Interaction in Healthy Adult Subjects

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06785181
Acronym
IDEALE
Enrollment
50
Registered
2025-01-21
Start date
2024-10-03
Completion date
2027-10-03
Last updated
2026-07-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Disease

Brief summary

IDEALE aims to assess the status of autonomic function, cerebral autoregulation (CA) and cortical activity in healthy subjects and correlate these functions with the psychological dimension of the subjects. To this end, parameters of cardiac, cortical, vascular and cerebrovascular variability derived from electrocardiographic, electroencephalographic, respiratory movement, blood pressure, transcranial Doppler signals will be acquired and analysed for each healthy volunteer (TCD) and Laser-Doppler transcutaneous, during a phase of clinostatism (REST) and one of active orthostatism (STAND). In addition, volunteers will be submitted to psychometric tests (Chieti Affective Action Videos, CAAV) to assess the presence of depressive symptoms.

Interventions

DIAGNOSTIC_TESTActive standing

a session at resting state in supine position, a session during autonomic challenge obtained via active standing evoking reflex sympathetic activation, and a session of emotional elicitation via the administration of videos

Sponsors

IRCCS Policlinico S. Donato
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* age older than 18 years * spontaneous sinus rhythm * signed informed consent

Exclusion criteria

* Definite diseases of the Autonomic Nervous System (SNA) or the cardiovascular system * Central nervous system disorders * subjects under drug therapy that may affect the cardiovascular system * pregnancy * previous diagnosis of depression

Design outcomes

Primary

MeasureTime frameDescription
Autoregulation index (ARI)36 monthsARI is an index describing the state of cerebral autoregulation from mean cerebral blood velocity and mean arterial pressure. Minimum value 0, maximum value 9. ARI\>4 means working autoregulation. ARI\<4 means impaired autoregulation. It will be computed for all participants.
Baroreflex sensitivity36 monthsBaroreflex sensitivity will be measured in ms/mmHg. Minimum value 0. Higher value means a better baroreflex regulation. It will be computed in all participants
Cortical activity36 monthsPower of EEG in Alpha and Beta band will be measured in square microvolt. Minimum value 0.

Countries

Italy

Contacts

CONTACTVlasta Bari, PhD
vlasta.bari@grupposandonato.it+390252774381
CONTACTPavandeep Singh
pavandeep.singh@grupposandonato.it+390252774381

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 7, 2026